Literature DB >> 12297511

Novel role for low molecular weight plasma thiols in nitric oxide-mediated control of platelet function.

Michael S Crane1, Richard Ollosson, Kevin P Moore, Adriano G Rossi, Ian L Megson.   

Abstract

Nitric oxide (NO) is a powerful antiplatelet agent, but its notoriously short biological half-life limits its potential to prevent the activation of circulating platelets. Here we used diethylamine diazeniumdiolate (DEA/NO) as an NO generator to determine whether the antiplatelet effects of NO are prolonged by the formation of a durable, plasma-borne S-nitrosothiol reservoir. Preincubation of both platelet rich plasma (PRP) and washed platelets (WP) with DEA/NO (2 microm) for 1 min inhibited collagen-induced platelet aggregation by 82 +/- 5 and 91 +/- 2%, respectively. After 30 min preincubation with DEA/NO, NO was no longer detectable in either preparation, but aggregation remained markedly inhibited (72 +/- 7%) in PRP. In contrast, the inhibitory effect in WP was almost completely lost at this time (5 +/- 3%) but was partially restored (39 +/- 10%) in WP containing human serum albumin (1%) and fully restored by co-incubation with albumin and the low molecular weight (LMW) thiols, glutathione, (5 microm), cysteinyl-glycine (10 microm), or cysteine (10 microm). This NO-mediated effect was not seen with LMW thiols in the absence of albumin and was associated with S-nitrosothiol formation. Our results demonstrate that LMW thiols play an important role in both the formation and activation of an S-nitrosoalbumin reservoir that significantly prolongs the duration of action of NO.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12297511     DOI: 10.1074/jbc.M208608200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Recent developments in nitric oxide donor drugs.

Authors:  M R Miller; I L Megson
Journal:  Br J Pharmacol       Date:  2007-04-02       Impact factor: 8.739

Review 2.  S-nitrosothiols as selective antithrombotic agents - possible mechanisms.

Authors:  M P Gordge; F Xiao
Journal:  Br J Pharmacol       Date:  2010-03-08       Impact factor: 8.739

3.  A potential role for extracellular nitric oxide generation in cGMP-independent inhibition of human platelet aggregation: biochemical and pharmacological considerations.

Authors:  Michael S Crane; Adriano G Rossi; Ian L Megson
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

4.  Effect of Nitric Oxide Donor on Metabolism of Apheresis Platelets.

Authors:  Lu Yu; Shifang Yu; Yunlei He; Qiming Li; Deyi Xu; Kai Huang; Gang Deng; Qiang Li
Journal:  Indian J Hematol Blood Transfus       Date:  2017-09-27       Impact factor: 0.900

5.  Mechanism of action of novel NO-releasing furoxan derivatives of aspirin in human platelets.

Authors:  Catriona M Turnbull; Clara Cena; Roberta Fruttero; Alberto Gasco; Adriano G Rossi; Ian L Megson
Journal:  Br J Pharmacol       Date:  2006-05-15       Impact factor: 8.739

Review 6.  Nitric oxide production pathways in erythrocytes and plasma.

Authors:  Kejing Chen; Aleksander S Popel
Journal:  Biorheology       Date:  2009       Impact factor: 1.875

7.  GEA 3162 decomposes to co-generate nitric oxide and superoxide and induces apoptosis in human neutrophils via a peroxynitrite-dependent mechanism.

Authors:  Emma L Taylor; Adriano G Rossi; Catherine A Shaw; Francesco P Dal Rio; Christopher Haslett; Ian L Megson
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

8.  Platelet aggregation is affected by nitrosothiols in patients with chronic hepatitis: in vivo and in vitro studies.

Authors:  A Federico; A Filippelli; M Falciani; C Tuccillo; A Tiso; A Floreani; R Naccarato; F Rossi; C Del Vecchio Blanco; C Loguercio
Journal:  World J Gastroenterol       Date:  2007-07-21       Impact factor: 5.742

9.  S-nitrosylated human serum albumin-mediated cytoprotective activity is enhanced by fatty acid binding.

Authors:  Yu Ishima; Takaaki Akaike; Ulrich Kragh-Hansen; Shuichi Hiroyama; Tomohiro Sawa; Ayaka Suenaga; Toru Maruyama; Toshiya Kai; Masaki Otagiri
Journal:  J Biol Chem       Date:  2008-10-20       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.